Janux Therapeutics stock surged Tuesday after the company found success during a Phase I trial for a novel prostate cancer ...

Shares of Janux Therapeutics Inc. surged over 54% on Tuesday afternoon, reaching levels not seen since May and breaking a ...

The TNM staging approach, which stands for tumour, nodes, and metastasis, is the most widely used method for staging prostate ...

The study of prostate cancer patients in the VA system found some with limited life expectancy were being treated with ...

Dr. Wong Siew Wei, from Parkway Hospital visited Sri Lanka to attend the Annual Academic Session at College of Oncology which ...

Menadione, a vitamin K precursor, shows promise in slowing prostate cancer in mice by disrupting cancer cell survival ...

Researchers have identified a new role for the enzyme EZH2 in promoting the progression of aggressive, treatment-resistant ...

Shares of Janux Therapeutics surged after its prostate cancer treatment was selected for expansion trials following what it called encouraging efficacy and safety results.

Benign Prostatic Hyperplasia (BPH), or an enlarged prostate, is a common condition in aging men that can cause urinary ...

Profound Medical (Nasdaq:PROF) today announced a co-sales and co-marketing agreement for imaging technology with Siemens ...